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AbSTR ACT
One of the characteristics of cancer is that the lack of oxygen 
in the cancer cells triggers changes in their gene expression. 
This hypoxia activates hypoxia-inducible factor 1-alpha and this 
in turn sets in motion the whole family of important angio-
genic genes for the tumour. Hypoxia-inducible factor 1-alpha 
therefore increases the density and vascular permeability 
within the tumours, facilitating their rapid growth and, later, 
the metastasis. Senecio graveolens is a South American me-
dicinal plant commonly used for mountain sickness (lack of 
adaptation of the organism to hypoxia). Additionally, pharma-
cological studies showed that its alcoholic extracts have cyto-
toxic properties. This research aimed to perform a guided 
phytochemical study of S. graveolens to identify compounds 
capable of inhibiting hypoxia-inducible factor 1-alpha through 
suppression of nuclear factor kappa-light-chain-enhancer 
of activated B cell activation. The isolation led to the charac-
terisation of phanurane (1), damsine (2), and scoparone (3), 
first reported in the S. graveolens species. Phanurane (1) 
showed inhibitory activity of hypoxia-inducible factor 1-alpha 
on the cancer cell lines U-373 MG (IC50 = 20.66 ± 0.04 μM), 
A549 (IC50 = 25.80 ± 0.04 μM), Hep G2 (IC50 = 29.21 ± 0.03 μM), 
and Caco-2 (IC50 = 38.58 ± 0.02 μM). Damsine (2) hypoxia-in-
ducible factor 1-alpha displayed inhibitory activity of hypoxia-
inducible factor 1-alpha on the cancer cell lines U-373 MG 
(IC50 = 2.29 ± 0.07 μM), A549 (IC50 = 4.13 ± 0.04 μM), Hep G2 
(IC50 = 6.40 ± 0.03 μM), and Caco-2 (IC50 = 9.80 ± 0.04 μM). Fi-
nally, scoparone (3) displayed inhibitory activity of hypoxia-
inducible factor 1-alpha on the cancer cell lines U-373 MG 
(IC50 = 15.22 ± 0.01 μM), A549 (IC50 = 17.47 ± 0.02 μM), Hep G2 
(IC50 = 18.26 ± 0.06 μM), and Caco-2 (IC50 = 19.75 ± 0.04 μM). In 
addition, phanurane (1) displayed inhibitory activity over nu-
clear factor kappa-light-chain-enhancer of activated B cells 
on cancer cell lines U-373 MG (IC50 = 7.13 ± 0.03 μM), A549 
(IC50 = 8.64 ± 0.03 μM), Hep G2 (IC50 = 8.87 ± 0.04 μM), and 
Caco-2 (IC50 = 15.11 ± 0.01 μM). Likewise, damsine (2) showed 
inhibitory activity over nuclear factor kappa-light-chain- 
enhancer of activated B cells on cancer cell lines U-373 MG 
(IC50 = 2.28 ± 0.01 μM), A549 (IC50 = 3.79 ± 0.02 μM), Hep G2 
(IC50 = 3.98 ± 0.05 μM), and Caco-2 (IC50 = 6.41 ± 0.02 μM). 
Lastly, scoparone (3) displayed inhibitory activity of nuclear 
factor kappa-light-chain-enhancer of activated B cells on 
cancer cell lines U-373 MG (IC50 = 3.62 ± 0.06 μM), A549 
(IC50 = 4.48 ± 0.03 μM), Hep G2 (IC50 = 5.25 ± 0.01 μM), and 
Caco-2 (IC50 = 11.90 ± 0.02 μM). This study corroborates the 
cytotoxic activity of the isolated compounds through the 
inhibition of hypoxia-inducible factor 1-alpha as well as its 
modulator nuclear factor kappa-light-chain-enhancer of acti-
vated B cells.
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AbbRevIATIoNS
ANGPT1 angiopoietin 1
BIRC5  baculoviral inhibitor of apoptosis repeat-con-
taining 5
CA9 carbonic anhydrase IX
EPO erythropoietin
GAPDH glyceraldehyde 3-phosphate dehydrogenase
GLUT-1 glucose transporter 1
HIF-1α hypoxia-inducible factor 1-alpha
ILs interleukins
LDHA lactate dehydrogenase A
LOX lysyl oxidase
MMP2 matrix metalloproteinase-2
MMP9 matrix metalloproteinase-9
NF-κB  nuclear factor kappa-light-chain-enhancer of 
activated B cells
PDK1  pyruvate dehydrogenase lipoamide kinase 
isozyme 1
PGK1 phosphoglycerate kinase 1
PKM2 pyruvate kinase isozymes M2
pVHL von Hippel-Lindau protein
RelA transcription factor p65
SDF1 stromal cell-derived factor 1
VEGF vascular endothelial growth factor
Introduction
Senecio graveolens Wedd. (synonym: Senecio nutans Sch. Bip) be-
longs to the family Asteraceae. S. graveolens, also known as 
“Chachakuma”, is a perennial shrub about 20–60 cm high that 
grows in habitats with heights fluctuating between 3500–5000 
metres above sea level in the Andes Chile, Argentina, Peru, and 
 Bolivia. It is a medicinal plant widely used by the communities liv-
ing in these areas in the form of an infusion and decoction. The in-
fusion of leaves and stems is used to ameliorate altitude sickness 
(principally as vasodilator preparations), headaches, stomach pain, 
intestinal inflammations, colitis, nausea, fever, pulmonary diseas-
es, and bronchitis [1–4]. The decoction of leaves, stems, and roots 
is used against all types of pulmonary affections such as a brain 
tonic and against nervousness and excessive sweating [1, 3–5]. 
Pharmacological studies have shown that the ethanolic extract of 
S. graveolens possesses cytotoxic activity in MCF-7 cancer cells at a 
concentration of 200 μg/mL [6].
Human cancers frequently contain areas of necrosis in which 
cancer cells have died due to inadequate oxygenation [7, 8]. Cells 
closest to a perfused blood vessel are exposed to relatively high O2 
concentrations, which decline as distance from the vessel increas-
es. Although such gradients exist in normal tissues, in cancers, the 
gradients are much steeper and O2 concentrations drop to near 
zero in areas of necrosis. In addition to physical gradients, tempo-
ral fluctuations in oxygenation also commonly occur within tu-
mours [9]. This activates HIF-1α, which in turn sets in motion the 
whole family of important genes that collaborate with different as-
pects essential for tumourigenesis and tumour progression, i. e., 
genes associated with angiogenesis (VEGF, SDF1, ANGPT1), sur-
vival (BIRC5, EPO), reprogramming from an oxidative metabolism 
to a glycolytic metabolism (GLUT-1, LDHA, PDK1, GAPDH, PGK1, 
PKM2), and epithelial-mesenchymal transition and metastasis 
(LOX, MMP2, MMP9) [10, 11].
HIF-1α therefore increases the density and vascular permeabil-
ity within the tumours facilitating their growth and later the feared 
metastasis, since the vessels are the outlet for cancer cells capable 
of colonising other tissues [12, 13]. Regardless of hypoxia, in some 
tumours, such as hemangioblastomas and renal carcinomas, the 
activation of HIF-1α is related to the functional inactivation of the 
suppressor gene for pVHL, which decreases degradation and in-
creases the total HIF-1α of the cell, even in normoxia [14, 15].
Under hypoxic conditions, phosphorylation of IκB and the sub-
sequent activation of the NF-κB subunits p50 and p65 (RelA) has 
been reported to contribute to basal levels of HIF-1α mRNA and 
protein, and to mediate HIF-1α expression and promoter activity 
in response to thrombin, H2O2, and even short-term hypoxia. In-
deed, the NF-κB subunits p50 and p65 have been shown to direct-
ly interact with HIF-1α at an NF-κB consensus site in the HIF-1α pro-
moter at -197/-188 bp under these conditions. In addition to the 
stabilisation of HIF-1α under hypoxia conditions, van Uden et al. 
[16] described how the NF-κB complex is a direct modulator of HIF-
1α expression in a manner dependent on stimulation with TNF-α 
in normoxic conditions [17–19].
The aim of the present research was to perform a bioguided phy-
tochemical study to identify compounds of S. graveolens with the 
capacity to inhibit HIF-1α through suppression of NF-κB activation 
as future antitumour compounds.
Results
Previously isolated compounds of the S. graveolens species belong 
to a range of structural groups such as monoterpenoids, germac-
renes, eremophilanes, sesquiterpenes, p-hydroxyacetophenone 
derivatives and shikimic acid derivatives, benzofurans, and benzo-
pyrans, which show a structural relationship with the previously 
unreported compounds isolated in this work [20–22]. Their struc-
tures were elucidated through 1H and 13C NMR, 2D spectroscopic, 
and HR-ESIMS analyses. Based on the reported data, they were 
identified as spironolactone (phanurane), sesquiterpene lactone 
(damsine), and coumarin (scoparone) (▶Fig. 1), isolated for the 
first time from this plant species.
U-373 MG (human glioblastoma astrocytoma), A549 (human 
Caucasian lung carcinoma), Hep G2 (human Caucasian hepatocyte 
carcinoma), and Caco-2 (human Caucasian colon adenocarcinoma) 
cancer cell lines were selected to carry out the in vitro cytotoxicity 
and activity assays of the S. graveolens extracts and compounds. 
We selected these cancer cell lines according to their physiological 
relationship with certain diseases that are treated with S. graveo-
lens in traditional medicine [1–4]. Therefore, the relationship is for 
mountain sickness, characterised by symptoms such as headache 
(U-373 MG cell line), respiratory diseases (A549 cell line), stomach 
pain, and colitis (Hep G2 and Caco-2 cell lines). In addition, a non-
cancerous cell line (PMBC) was used to assess the safety of the com-
pounds.
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After examining the cytotoxicity of the S. graveolens extracts in 
hypoxic conditions (1 % O2) after 72 h of treatment (▶Table 1), we 
observed that all of them had a greater cytotoxic effect on the can-
cer cell line U-373 MG, which is a human glioblastoma astrocyto-
ma cell line. We also observed that the dichloromethane/methanol 
extract was more active than the aqueous extract and the n-hep-
tanic extract. These results corroborate those shown by Echiburú-
Chau et al. [6], who by means of the neutral red uptake test ob-
served that at a concentration of 200 μg/mL ethanolic extract of 
S. graveolens exhibited cytotoxicity in breast cancer cell lines ZR-
75–1, MCF-7, and MDA-MB-231 at 24 h of treatment under hypox-
ic conditions, without damaging the MCF-10F cell line. However, 
at this concentration, the ethanolic extract of S. graveolens showed 
a greater cytotoxic effect on the cell line MDA-MB-231 (50 %) com-
pared to the other cancer lines ZR-75–1 (9 %) and MCF-7 (6 %) [6]. 
Finally, both MTT and LDH assays showed that dichloromethane/
methanol and aqueous extracts have cytotoxic effects higher than 
100 μg/mL in the PBMCs. On the contrary, the n-heptanic extract 
was discarded due to its cytotoxic effect in PBMCs with a CC50 of 
99.62 ± 2.22 μg/mL and 91.02 ± 3.60 μg/mL measured by the MTT 
and LDH assays, respectively.
Afterwards, we evaluated the dichloromethane/methanol and 
the aqueous extracts inhibitory activity over NF-κB (▶Table 2) and 
HIF-1α (▶Table 3) on the same cell lines under equal conditions. 
The dichloromethane/methanol extract presented a higher inhib-
itory effect on both transcription factors in all cell lines. Again, the 
lower IC50 values were those shown on the brain cancer cell line 
O
O
O O O O
OO
H
H
H
H
H3CO
H3COHH
(1) (2) (3)
▶Fig. 1 Chemical structures Phanurane (1), Damsine (2) and Scoparone (3).
▶Table 1 MTT and LDH cytotoxicity assays of S. graveolens extracts against a panel of human cancer cell lines and one noncancerous cell line after 72 h of 
treatment under hypoxic (1 % O2) conditions. The results are the means ( ± SD) of three separate experiments performed in triplicate. Control = untreated 
cells.
Samples CC50 (µg/mL)
PbMCs U-373 MG A549 Hep G2 Caco-2
Control (untreated cells) 100.01 ± 3.45 100.00 ± 1.23 99.95 ± 1.87 99.98 ± 2.67 100.10 ± 2.21
Heptanic extract(a) 99.62 ± 2.22 41.74 ± 1.62 57.15 ± 2.42 78.66 ± 2.67 98.79 ± 4.62
Dichloromethane/methanol extract(a)  > 100 ± 1.64 31.40 ± 2.32 46.52 ± 2.26 68.97 ± 3.66 98.05 ± 3.67
Aqueous extract(a)  > 100 ± 1.75 33.48 ± 4.81 47.84 ± 2.67 74.73 ± 2.69 98.46 ± 1.65
Control (untreated cells) 99.96 ± 3.45 99.90 ± 2.65 100.11 ± 3.11 99.92 ± 2.87 100.09 ± 2.74
Heptanic extract(b) 91.02 ± 3.60 40.08 ± 1.46 54.24 ± 4.36 76.21 ± 3.50 95.71 ± 2.67
Dichloromethane/methanol extract(b)  > 100 ± 1.09 31.38 ± 1.95 42.02 ± 1.71 66.18 ± 2.05 94.93 ± 1.85
Aqueous extract(b)  > 100 ± 1.56 31.94 ± 2.09 47.12 ± 2.40 74.50 ± 1.37 95.63 ± 3.48
(a) Cytotoxicity values of the MTT assay; (b) Cytotoxicity values of the LDH assay
▶Table 2 Inhibitory effect of S. graveolens extracts on NF-κB activation in a panel of human cancer cell lines and one noncancerous cell line after 72 h of 
treatment under hypoxic (1 % O2) conditions. The results are the means ( ± SD) of three separate experiments performed in triplicate. Control = untreated 
cells.
Samples CC50 (µg/mL)
PbMCs U-373 MG A549 Hep G2 Caco-2
Control 11.98 ± 0.01 12.43 ± 0.01 12.23 ± 0.08 12.45 ± 0.09 12.65 ± 0.08
DMSO 5.96 ± 0.05 6.35 ± 0.02 6.45 ± 0.03 6.23 ± 0.07 6.62 ± 0.08
Dichloromethane/methanol extract 3.89 ± 0.01 4.40 ± 0.02 5.35 ± 0.01 9.58 ± 0.04 10.44 ± 0.01
Aqueous extract 14.56 ± 0.02 20.29 ± 0.05 27.24 ± 0.02 30.23 ± 0.04 39.89 ± 0.03
JSH-23 7.09 ± 0.01 µM 6.99 ± 0.02 µM 7.10 ± 0.02 µM 7.10 ± 0.03 µM 7.11 ± 0.01 µM
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U-373 MG in comparison with the rest of the cancerous cell lines. 
Nevertheless, the inhibitory effect was even higher on the PBMCs.
For the fractionation and isolation of the compounds of S. gra-
veolens, the dichloromethane/methanol extract was selected be-
cause it showed no cytotoxic effect on the PBMCs, besides show-
ing greater inhibitory activity over NF-κB and HIF-1α with respect 
to the aqueous extract.
Regarding the compounds (phanurane, damsine, and scopar-
one) isolated from the dichloromethane/methanol extract of 
S. graveolens, they were individually more cytotoxic than the crude 
extract in the same hypoxic conditions (1 % O2) at 72 h of treatment. 
U-373 MG cell line viability remained as the most affected one by 
the three compounds with respect to the cancer cell lines A549, 
Hep G2, and Caco-2 (▶Table 4). Besides, the isolated compounds 
did not show a cytotoxicity higher than 100 μM on the noncancer-
ous cell line (PBMCs) by the MTT assay. However, in the LDH assay, 
phanurane, damsine, and scoparone compounds showed CC50s of 
90.11 ± 0.99, 79.62 ± 2.23 , and 89.79 ± 1.12 μM on the PBMCs.
Phanurane (1) showed a cytotoxic effect by means of the MTT 
assay under hypoxic conditions (1 % O2) on the cancer cell lines 
U-373 MG, A549, Hep G2, and Caco-2 with CC50s of 23.63 ± 1.47, 
28.54 ± 2.25, 45.33 ± 1.09, and 68.49 ± 3.50 μM at 72 h of treat-
ment. However, using the LDH assay under hypoxic conditions (1 % 
O2) at 72 h of treatment, phanurane showed CC50s of 21.30 ± 1.09, 
27.44 ± 3.18, 44.47 ± 1.77, and 67.89 ± 1.38 μM on the cancer lines 
mentioned above. There are no reports of phanurane cytotoxicity 
assays on cell lines.
Damsine (2) showed a cytotoxic effect by means of the MTT and 
LDH assays under hypoxic conditions (1 % O2) at 72 h of treatment 
on the cancer cell lines U-373 MG, A549, Hep G2, and Caco-2 with 
CC50s of 12.40 ± 2.28, 23.80 ± 1.06, 39.07 ± 2.43, 63.79 ± 1.48 μM 
and 12.25 ± 1.10, 21.91 ± 2.66, 35.09 ± 3.05, 60.76 ± 1.12 μM, re-
spectively. Our results corroborate the cytotoxic activity of dam-
sine described by Saeed et al. [23], who observed cytotoxic activ-
ity (as measured by the resazurin reduction assay) at 24 h of dam-
sine treatment on brain and colon cancer cell lines U87 MG/U87 
ΔEGFR and HCT116. P53 + / + /HCT116 P53-/- with CC50s of 
154.4 ± 8.9/24.1 ± 1.5 μM and 32.5 ± 6/133.6 ± 18.4 μM, respective-
ly. In addition, there are reports that damsine has cytotoxic activ-
ity at 72 h of treatment on breast cancer cell lines MCF-7, JIMT-1, 
and HCC1937 with CC50s of 3.7 ± 0.4, 3.3 ± 0.6, and 6.8 ± 0.4 μM, 
respectively [24].
Scoparone (3) showed a cytotoxic effect under hypoxic condi-
tions (1 % O2) with CC50s of 18.47 ± 1.49, 24.67 ± 1.34, 41.92 ± 2.39, 
and 66.39 ± 2.75 μM by means of the MTT assay and 16.84 ± 2.80, 
23.82 ± 2.40, 41.59 ± 2.66, and 64.42 ± 1.76 μM by means of the 
LDH assay on the cancer cell lines U-373 MG, A549, Hep G2, and 
Caco-2 after 72 h of treatment. There are also reports that scopar-
one significantly inhibited the proliferation of DU145 cells, with a 
CC50 value of 41.3 μM after 72 h of treatment [25].
Concerning the inhibition of NF-κB production in hypoxic con-
ditions (1 % O2), the isolated compounds of the dichloromethane/
methanol extract of S. graveolens were compared with respect to 
the positive control JSH-23 (IC50 = 7.1 µM) [26]. Phanurane, dam-
sine, and scoparone compounds showed a greater effect on the 
brain cancer cell line with respect to the lung, liver, and colon can-
cer cell lines after 72 h of treatment (▶Fig. 2).
Phanurane (1) inhibited the production of NF-κB under hypoxic 
(1 % O2) conditions on the cancer cell lines U-373 MG, A549, Hep 
G2, and Caco-2 with IC50s of 7.13 ± 0.03, 8.64 ± 0.03, 8.87 ± 0.04, 
▶Table 3 Inhibitory effect of S. graveolens extracts on HIF-1α in a panel of human cancer cell lines and one noncancerous cell line after 72 h of treatment 
under hypoxic (1 % O2) conditions. Control = untreated cells.
Samples CC50 (µg/mL)
PbMCs U-373 MG A549 Hep G2 Caco-2
Control 90.97 ± 0.02 96.71 ± 0.05 98.84 ± 0.05 97.82 ± 0.06 99.97 ± 0.03
Dichloromethane/methanol extract 6.26 ± 0.09 9.39 ± 0.03 15.72 ± 0.06 19.63 ± 0.05 32.51 ± 0.07
Aqueous extract 20.25 ± 0.09 25.87 ± 0.08 30.22 ± 0.07 41.89 ± 0.02 84.89 ± 0.05
2-MeOE2 0.49 ± 0.02 µM 0.48 ± 0.01 µM 0.50 ± 0.01 µM 0.49 ± 0.02 µM 0.51 ± 0.02 µM
▶Table 4 MTT and LDH cytotoxicity assays of S. graveolens compounds against a panel of human cancer cell lines and one noncancerous cell line after 72 h 
of treatment under hypoxic (1 % O2) conditions. Control = untreated cells.
Samples CC50 (µg/mL)
PbMCs U-373 MG A549 Hep G2 Caco-2
Control (untreated cells) 99.98 ± 2.12 99.97 ± 3.43 100.01 ± 2.16 100.18 ± 3.07 99.90 ± 3.11
Compound 1(a)  > 100 ± 2.51 23.63 ± 1.47 28.54 ± 2.25 45.33 ± 1.09 68.49 ± 3.50
Compound 2(a)  > 100 ± 3.28 12.40 ± 2.28 23.80 ± 1.06 39.07 ± 2.43 63.79 ± 1.48
Compound 3(a)  > 100 ± 1.25 18.47 ± 1.49 24.67 ± 1.34 41.92 ± 2.39 66.39 ± 2.75
Control (untreated cells) 100.03 ± 2.11 100.97 ± 3.11 100.91 ± 2.91 100.95 ± 3.43 99.91 ± 3.56
Compound 1(b) 90.11 ± 0.99 21.30 ± 1.09 27.44 ± 3.18 44.47 ± 1.77 67.89 ± 1.38
Compound 2(b) 79.62 ± 2.23 12.25 ± 1.10 21.91 ± 2.66 35.09 ± 3.05 60.76 ± 1.12
Compound 3(b) 89.79 ± 1.12 16.84 ± 2.80 23.82 ± 2.40 41.59 ± 2.66 64.42 ± 1.76
(a)Cytotoxicity values of the MTT assay; (b)Cytotoxicity values of the LDH assay.
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and 15.11 ± 0.01 μM at 72 h of treatment. There are no reports that 
phanurane has inhibited the production of NF-κB in cancer cell lines.
Damsine (2) inhibited the production of NF-κB under hypoxic 
(1 % O2) conditions at 72 h of treatment with IC50s of 2.28 ± 0.01, 
3.79 ± 0.02, 3.98 ± 0.05, and 6.41 ± 0.02 μM on cancer cells U-373 
MG, A549, Hep G2, and Caco-2, respectively. Also, there are re-
ports that damsine inhibited the expression of NF-κB on cancer cell 
line Caco-2 with an IC50 of 7.2 μM after 6 h of treatment [27].
Scoparone (3) inhibited the production of NF-κB under hypoxic 
(1 % O2) conditions at 72 h of treatment on the cancer cell lines 
U-373 MG, A549, Hep G2, and Caco-2 with IC50s of 3.62 ± 0.06, 
4.48 ± 0.03, 5.25 ± 0.01, and 11.90 ± 0.02 μM, respectively. Scop-
arone has also been reported to inhibit the expression of NF-κB on 
cancer cell line U-937 with an IC50 of 10 nM after 24 h of treatment 
[28].
Finally, under hypoxic conditions, the isolated compounds of 
the dichloromethane/methanol extract of S. graveolens were com-
pared with respect to the positive control 2-MeOE2 (IC50 = 0.5 µM) 
[29]. Phanurane, damsine, and scoparone compounds showed an 
inhibitory effect on HIF-1α on the cancer cell lines U-373 MG, A549, 
Hep G2, and Caco-2 at 72 h of treatment (▶Fig. 3).
Phanurane (1) inhibited HIF-1α under hypoxic (1 % O2) condi-
tions at 72 h of treatment with IC50s of 20.66 ± 0.04, 25.80 ± 0.04, 
29.21 ± 0.03, and 38.58 ± 0.02 μM on cancer cells U-373 MG, A549, 
Hep G2, and Caco-2, respectively.
Damsine (2), under hypoxic (1 % O2) conditions at 72 h of treat-
ment on the cancer cell lines U-373 MG, A549, Hep G2, and Caco-2, 
inhibited HIF-1α with IC50s of 2.29 ± 0.07, 4.13 ± 0.04, 6.40 ± 0.03, 
and 9.80 ± 0.04 μM, respectively.
Scoparone (3) inhibited HIF-1α under hypoxic (1 % O2) conditions 
on the cancer cell lines U-373 MG, A549, Hep G2, and Caco-2 with 
IC 50s  of  15.22 ± 0.01,  17.47 ± 0.02,  18.26 ± 0.06,  and 
19.75 ± 0.04 μM, respectively, at 72 h of treatment.
There are no reports on the inhibition of HIF-1α by means of the 
phanurane, damsine, and scoparone compounds.
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▶Fig. 2 Inhibitory effect of S. graveolens compounds on NF-κB activation in a panel of human cancer cell lines and one noncancer cell line after 72 h 
of treatment under hypoxic (1 % O2) conditions. Control = untreated cells.
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Discussion
There is an extensive phytochemical analysis on the essential 
oil (46 compounds) of S. graveolens, where monoterpene hydro-
carbons predominate, with sabinene and α-terpinene as the 
main components [30, 31]. The main activity of the essential oil of 
S. graveolens is antimicrobial [32, 33]. On the other hand, only 14 
compounds present in the hydroalcoholic extract have been iden-
tified from the aerial parts of S. graveolens. The compounds dihy-
droeuparin, 4-hydroxy-3-(isopenten-2-yl) acetophenone, 3-hy-
droxy-2,2-dimethyl-6-acetylchromane, 5-acetylsalicylaldehyde, 
4-hydroxy-3-(3'-hydroxyisopentyl) acetophenone, scopoletin, 
3-phenyl-4-hydroxyacetophenone, 4-hydroxyacetophenone, 4-hy-
droxy-3-methoxyacetophenone, 4-hydroxy-3-(3-methyl-2-bute-
nyl) acetophenone, 5-acetyl-6-hydroxy-2-isopropenyl-2,3-dihyd-
robenzofurane, 4-acetylphenyl-α-D-glucopyranoside, 1-(3-hy-
droxy-2,2-dimethyl-3,4-dihydro-2H-chromen-6-yl) ethanone, and 
1-(2,2-dimethyl-3,4-dihydro-2H-chromen-6-yl) ethanone are poly-
phenolic in nature [20–22, 34]. There are few works on the phar-
macological activities of S. graveolens. With respect to the hydroal-
coholic extract of S. graveolens, only antimicrobial, antioxidant, vas-
odilator, hypotensive, and antihypertensive activities have been 
tested. [34–37].
Regarding the cytotoxicity of S. graveolens, Echiburú-Chau et al. 
[6] reported that the alcoholic extract could induce cytotoxicity 
under hypoxic conditions in different breast cancer cell lines (ZR-
75–1, MCF-7, and MDA-MB-231), but not in non-tumourigenic cells 
(MCF-10F). However, compound 4-hydroxy-3-(3-methyl-2-bute-
nyl) acetophenone, mostly present in the alcoholic extract, did not 
show effective anticancer activity compared to the complete ex-
tract. The mechanisms responsible for the cytotoxicity exerted by 
the alcoholic extract of S. graveolens are not clear. It is very likely 
that the relative contribution of apoptosis and autophagy to the 
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▶Fig. 3 Inhibitory effect of S. graveolens compounds on HIF-1α in a panel of human cancer cell lines and one noncancer cell line after 72 h of treat-
ment under hypoxic (1 % O2) conditions. Control = untreated cells.
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cytotoxic effects of S. graveolens depends mainly on the genetic 
profile of the analysed cells, since alterations in the known onco-
genic pathways (for example, P53) modify the way in which a cell 
responds to external stimuli.
Our study revealed that the dichloromethane/methanol extract 
of S. graveolens showed a greater inhibitory activity on NF-κB and 
HIF-1α than the aqueous extract of S. graveolens in all tumour cell 
lines (U-373 MG, A549, Hep G2, Caco-2) tested. Besides, both ex-
tracts did not show cytotoxicity over PBMCs non-tumourous cell 
line. We also observed that the n-heptanic extract of S. graveolens 
presented cytotoxicity over PBMCs non-tumourous cell line, and 
its activity over NF-κB and HIF-1α was lower with respect to the di-
chloromethane/methanol and aqueous extracts. For that reason, 
we selected the dichloromethane/methanol extract for subsequent 
fractionation. The dichloromethane/methanol extract was sepa-
rated by bioguided analysis, determining the activity of each frac-
tion over NF-κB and HIF-1α (data not shown).
The interest in the role of HIF-1 in cancer biology has grown ex-
ponentially because the usual conditions within most solid tumour 
masses occur are anoxia (absence of oxygen) or hypoxia (low oxy-
gen concentrations). These situations activate HIF-1 protein, which 
consists of two subunits, α1 (inducible), and β1 (constitutively ex-
pressed). Under normoxia conditions (normal oxygen concentra-
tions), the α1 subunit is very labile, and degrades at the same rate 
at which it is synthesised [38]. However, under hypoxia conditions, 
this subunit is stabilised and dimerizes with the β1 subunit. This 
heterodimer migrates to the nucleus, where it binds to specific DNA 
sequences, activating genes involved in adaptation to hypoxia, cell 
survival, angiogenesis, and metastasis, such as, for example, VEGF, 
TGF-a, GLUT-1, or CA9, among many others, which we know are 
involved in tumour development and aggressiveness [39–41]. Also, 
HIF-1α has been shown to be regulated by cytokines such as ILs, 
TNF-α, and NF-κB [42].
NF-κB is a central molecule that regulates the expression of var-
ious target genes that promote cell proliferation, modulate im-
mune responses, and play a role in the pathogenesis of various dis-
eases, including cancer [43, 44]. When analysing the possible 
mechanism by NF-κB inhibition of the compounds isolated from 
the dichloromethane/methanol extract of S. graveolens, we could 
indicate that damsine acts on sulfhydryl groups of cysteine resi-
dues in the DNA-binding domain of the NF-κB subunit through its 
exomethylene group [45]. Likewise, the unsaturated carbonyl 
group and the methylene-lactone ring present in damsine can exert 
a direct alkylation effect on the p65 subunit of NF-κB without in-
hibiting the degradation of IκB [46]. In the case of scoparone, the 
presence of its lactonic ring can inhibit the levels of the NF-κB-DNA 
complex. It can also inhibit dose-dependent phosphorylation of 
IκBα and nuclear translocation of NF-κB1 [47]. Finally, the low ac-
tivity of phanurane can be attributed to its lactonic ring, which par-
tially inhibits one of the stages of the cytoplasmic signalling path-
way of NF-κB and the nucleus, namely, the phosphorylation of IκBα 
in the cytoplasm [48]. The damsine and scoparone compounds had 
a better inhibitory activity on NF-κB than the JSH-23 control 
(IC50 = 7.1 µM) in all tumour cell lines, except in the Caco-2 cell line 
(▶Fig. 2).
Regarding the mechanism of inhibitory action over HIF-1α by 
the compounds isolated from the dichloromethane/methanol ex-
tract of S. graveolens, we could indicate, based on the bioinformat-
ic experiment conducted by Dawood et al. [50], that sesquiterpene 
lactones inhibiting NF-κB also possess the ability to inhibit HDAC 
(histone deacetylase). The latter leads to the inhibition of HIF-α in 
different tumour cell lines. This phenomenon is suggested as a 
mechanism of collateral sensitivity [49]. In the case of scoparone, 
like other coumarins, it would cause degradation of HIF-1α, weak-
ening glycolysis and all activities related to apoptosis in tumour 
cells [50]. Finally, regarding phanurane, there is no clear mecha-
nism of its activity on HIF-1α. There is a report by Yim et al. [51] 
which mentions that spironolactone (compound structurally sim-
ilar to phanurane) improved the hypoxic response and increased 
the expressions of HIF-1α and Ets-1 in the kidneys of newborn rats. 
However, they indicate that to clarify the hypoxic changes, it is nec-
essary to investigate what types of signal cascades exist between 
RAAS (renin-angiotensin-aldosterone system) and renal hypoxia. 
These results corroborate our results, since the phanurane com-
pound did not inhibit the activity of HIF-1α in the tumour cell lines 
analysed. On the contrary, we can indicate that phanurane in-
creased its activity. None of the compounds showed a better inhib-
itory activity over HIF-1α than the 2-MeOE2 control (IC50 = 0.5 µM) 
in all tumour cell lines (▶Fig. 3).
It should be noted that in the work of Echiburú-Chau et al. [6] 
they mentioned that the majority compound [4-hydroxy-3- (3-me-
thyl-2-butenyl) acetophenone] of the alcoholic extract presented 
less cytotoxic activity on different tumour cellular lines than the 
complete extract. However, in our case, the major compounds 
(phanurane, damsine, and scoparone) of the dichloromethane/
methanol extract showed greater cytotoxic activity over different 
tumour cellular lines than the complete extract (▶Table 3).
Both HIF-1α and NF-κB are involved in cancer progression and 
have been implicated in the tumour responses to hypoxia [52]. 
Moreover, positive correlations between HIF-1α and NF-κB have 
been shown in various cancer cells, including lung cancer cells, colo-
rectal cancer cells, osteosarcoma, and gastric cancer cells [53, 54]. 
Our results corroborate that both HIF-1α and NF-κB are involved in 
the progression of cancer and have been implicated in tumour re-
sponses to hypoxia. In addition, we have shown positive correla-
tions between HIF-1α and NF-κB in cancer cells lines U-373 MG, 
A549, Hep G2, and Caco-2. Likewise, it is the first time that the in-
hibitory activity over HIF-1α is reported by means of the phanu-
rane, damsine, and scoparone compounds, in addition to report-
ing for the first time the inhibitory activity of phanurane in NF-κB. 
Finally, we indicate, based on our results, that the inhibition of NF-
κB could regulate both HIF-1α signalling and the progression of the 
epithelial-mesenchymal transition induced by hypoxia.
In conclusion, considering the multiple roles of HIF-1α in tumour 
progression and metastasis, phanurane, damsine, and scoparone 
compounds must be considered prototype molecules for the de-
velopment of novel drugs aimed at inhibiting this pathway, due to 
their high cytotoxic capacity over different cancer cell lines. Since 
the HIF-1α regulatory pathway is a highly complex network involv-
ing several signalling cascades and overlapping mechanisms, each 
one of them could serve as a promising target or step to intervene 
tumours in the future.
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Materials and Methods
Cell lines, chemicals. and biochemicals
Four human cancer cell lines were used in this study: U-373 MG, 
A549, Hep G2, and Caco-2, and the non-tumourigenic PBMCs cell 
line. All cell lines were obtained from ATCC. Cells were cultured in 
specific media according to ATCC recommendations. PMBCs were 
obtained from whole blood by density gradient centrifugation 
using Lymphoprep (StemCell Technologies) according to the man-
ufacturer's instructions. In both cases, the incubation condition 
was established at 37 °C in hypoxic conditions (1 % O2), thus mim-
icking the in vivo tumour microenvironment.
We used first grade organic solvents for isolating the com-
pounds. TLC was performed using Merck Silica gel 60-F254 plates. 
Chromatograms thus obtained were visualised by UV absorbance 
(254 nm) and through heating a plate stained with phosphomolyb-
dic acid. Manual flash chromatography was performed with flash 
grade Silica gel 60 (20–45 and 40–63 μM; Merck).
DMEM, RPMI, FBS, and PBS were obtained from Sigma-Aldrich. 
L-Glutamine was obtained from Applichem. Penicillin and strepto-
mycin were purchased from PAA. Test compounds were dissolved 
in DMSO (Merck) at a 10 mM concentration, while the extracts and 
fractions were dissolved at 20 mg/mL in DMSO.
Plant material
A sample of S. graveolens was collected from the Pongo communi-
ty (Murillo province, La Paz, Bolivia) in August 2018 at an altitude 
of 3800 m. Botanical identification was confirmed by the National 
Herbarium of Bolivia (No. 13898).
Extraction and isolation
S. graveolens leaves (2 kg) were extracted by repeated maceration 
with 2.5 L of different solvents, increasing the polarity: n-heptane, 
dichloromethane/methanol (1:1), and water. As a result, three ex-
tracts of 120, 95, and 375 g, respectively, were obtained.
Each extract was evaluated for its cytotoxic effects and its influ-
ence on the inhibition of HIF-1α as well as on its modulator NF-κB. 
Only the n-heptanic extract showed significant cytotoxicity on the 
noncancerous cell line (▶Table 1), whereas the dichloromethane/
methanol extract showed a greater inhibition of NF-κB and HIF-1α, 
being more active than the aqueous extract (▶Tables 2 and ▶3). 
Therefore, the chemical constituents of the dichloromethane/
methanol extract were investigated to identify specific compounds 
with cytotoxic potential.
The dichloromethane/methanol extract was analysed through 
bioassay-guided Silica gel (40–63 μM) column chromatography (2  × 
50 cm) using a step gradient of n-heptane, dichloromethane and 
ethyl acetate (50/50/0 to 50/0/50) to produce 15 fractions (I-XV). 
Among them, III and IV were the fractions that showed the highest 
activity (inhibition of HIF-1α as well as of its modulator NF-κB).
As a result, fractions III and IV were combined and a second bi-
oassay-guided Silica gel (40–63 μM) column chromatography (2  × 
50 cm) was performed using step gradient n-heptane and dichlo-
romethane (50/0 to 0/50). Nine fractions were obtained (1–9). Nine 
fractions showed inhibition of HIF-1α as well as of its modulator 
NF-κB, but fractions 1, 5, and 7 were the most active.
Fraction 1 was separated in a column (2 × 30 cm) of Silica gel 
(40–63 μM) with n-heptane/ethyl acetate, 80:20, from which six 
fractions were obtained (1a-1f). Fraction 1b was the most active 
and it was further chromatographed in a column (2  ×  30 cm) of Sil-
ica gel (20–45 μM) (n-heptane/ethyl acetate, 60:40), obtaining 
compound 1 (14 mg).
Next, fraction 5 was chromatographed on a column (2 × 30 cm) 
of Silica gel (40–63 μM) with n-heptane/ethyl acetate, 60:40, to 
produce nine fractions (5a–5i), with the 5f fraction being the most 
active one. Fraction 5f was chromatographed in a column (2  × 
30 cm) of Silica gel (20–45 μM) (n-heptane/ethyl acetate, 50:50) to 
isolate compound 2 (11 mg).
Finally, fraction 7 was fractionated by a column (2 × 30 cm) of 
Silica gel (40–63 μM) with n-heptane/ethyl acetate, 20:80, provid-
ing ten fractions (7a–7j), from which fraction 7i was chromato-
graphed in a column (2  ×  30 cm) of Silica gel (20–45 μM) (n-hep-
tane/ethyl acetate, 40:60) to obtain compound 3 (5 mg).
NMR/MS analysis
NMR experiments were performed on a Bruker BioSpin GmbH spec-
trometer operating at 700 MHz (1H) or 175 MHz (13C). Deuterated 
solvents were methanol-d4 and chloroform-d1. Spectra were cali-
brated by assignment of the residual solvent peak to δH 3.31 ppm 
and δC 49.0 ppm for methanol-d4, and δH 7.2 ppm and δC 77.0 ppm 
for chloroform-d1. Complete assignment of protons and carbons 
was done by analysing the correlated 1H-1H COSY, 1H-13C HSQC, 
and 1H-13C HMBC spectra. HREIMS analyses were performed using 
a mass spectrometer with QTOF hybrid analyser model Q-Star Pul-
sar I from the commercial house Applied Biosystems. MS samples 
were prepared in MeOH  +  formic acid 0.1 % and analysed by the 
electrospray ionisation technique in the positive ion detection 
mode.
Cytotoxic assay
Cell viability was determined in a panel of four human cancer cell 
lines (U-373 MG, A549, Hep G2, Caco-2) and one noncancerous 
cell line (PBMCs) by MTT ( ≥  97.5 %, Sigma-Aldrich) and LDH (Cyto-
toxicity Detection Kit; Sigma-Aldrich) assays. Cells were seeded in 
96-well plates at a density of 2 × 104 cells/well, and then they were 
left for 24 h at 37 °C in a humidified atmosphere with 5 % CO2. After 
that, cells were treated with various concentrations (100, 50, 25, 
12.5, 6.25, 3.125, 1.563, 0.781, 0.391, and 0.95 µM) of the isolat-
ed compounds in hypoxic conditions (1 % O2).
MTT cytotoxicity assay: Following a 72-h incubation, a volume 
of 20 μL PBS containing 4 mg/mL MTT was added to each well. After 
this, plates were incubated for 4 h, before they were centrifuged at 
1500 rpm at 4 °C for 10 min, followed by the removal of the super-
natant. Then, DMSO (150 μL) was added to each well for coloura-
tion, and the plates were subsequently shaken vigorously to ensure 
complete solubilisation for 10 min at room temperature. The light 
absorption (OD, optical densities) was recorded on a spectropho-
tometric ELISA plate reader (SpectraMax i3, Molecular Devices) at 
a wavelength of 590 nm.
LDH cytotoxicity assay: After 72 h of treatment with the com-
pounds, 100 μL of culture supernatants were collected and incu-
bated in the reaction mixture from the LDH kit (Innoprot Compa-
ny). After 30 min, the reaction was stopped by adding HCl 1 N, and 
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the absorbance at a wavelength of 490 nm was measured using a 
spectrophotometric ELISA plate reader (SpectraMax i3; Molecular 
Devices).
Nuclear factor kappa-light-chain-enhancer of 
activated B cells inhibition assay
Cells were transfected using a lipofectamine plus transfection rea-
gent (Thermo Fisher Scientific) with 0.3 μg of the NF-κB-promoted 
luciferase reporter gene plasmid (pGL2-NF-κB-Luc) (Promega), and 
0.03 μg of the Renilla luciferase reporter plasmid (pTK-Renilla) 
(transfection normalisation vector; Promega). After 1 day, the cells 
were incubated with TNF-α (5 ng/mL) in the absence or presence 
of the isolated compounds at different concentrations (100, 50, 
25, 12.5, 6.25, 3.125, 1.563, 0.781, 0.391, and 0.95 µM) for 72 h 
of treatment in hypoxic conditions (1 % O2). JSH-23 ( ≥  98 %; Sigma-
Aldrich) was used as a positive control at a concentration of 7.1 µM. 
Next, the cells were lysed in 25 mM Tris-phosphate, pH 7.8, con-
taining 8 mM MgCl2, 1 mM dithiothreitol (DTT), 1 % Triton X-100, 
and 7 % glycerol. Luciferase activity was measured by a Dual-Lucif-
erase Reporter Assay Kit (Promega) according to the manufactur-
er’s instructions.
Hypoxia-inducible factor 1-alpha inhibition assay
Cells were stably transfected with plasmid Epo-Luc plasmid. EPO-
hypoxia response element (HRE)-luciferase reporter plasmid con-
tains three copies of the HRE consensus sequence from the pro-
moter of the erythropoietin gene in the pGL3 vector. Cells (1  ×  104) 
were seeded the day before the assay. The next day, the cells were 
stimulated with the test compounds at different concentrations 
(100, 50, 25, 12.5, 6.25, 3.125, 1563, 0.781, 0.391, and 0.95 μM). 
2-MeOE2 ( ≥  99 %; Sigma-Aldrich) was used as a positive control at 
a concentration of 0.5 µM. After 72 h of stimulation in hypoxic con-
ditions (1 % O2), the cells were lysed in 25 mM Tris-phosphate pH 
7.8, 8 mM MgCl2, 1 mM DTT, 1 % Triton X-100, and 7 % glycerol dur-
ing 15 min at RT in a horizontal shaker. Luciferase activity was meas-
ured using a GloMax 96 microplate luminometer (Promega) fol-
lowing the instructions of the luciferase assay kit (Promega). The 
RLU was calculated and the results are expressed as percentage of 
inhibition induction/inhibition of EPO-luc activity. Experiments for 
each concentration of the test items were done in triplicate wells.
Statistical analysis
Statistical significance of differences was calculated employing 
GraphPad Prism software, version 8.2.0 (GraphPad Software Inc.) 
using one-way ANOVA followed by Tukey’s post hoc test for multi-
ple comparisons. Results were considered different when 
p < 0.0001. IC50 values were determined by nonlinear regression 
using GraphPad Prism, version 8.2.0. All the experiments were per-
formed in triplicate.
Phanurane (1): white amorphous powder; m.p. = 149ºC; 1H-
NMR (700 MHz, CDCl3) δH = 6.14 (1H, dd, J = 9.8, 2.7 Hz, H-6), 6.09 
(1H, dd, J = 9.7, 2.0 Hz, H-7), 5.69 (1H, s, H-4), 2.58 (1H, m, H-21), 
2.55 (1H, m, H-2), 2.50 (1H, m, H-21’), 2.42 (1H, m, H-2'), 2.37 (1H, 
ddd, J = 13.0, 9.1, 6.1 Hz, H-20), 2.31 (1H, m, H-16), 2.30 (1H, m, 
H-8), 2.02 (1H, ddd, J = 13.1, 5.4, 2.1 Hz, H-1), 1.92 (1H, ddd, 
J = 12.8, 9.2, 7.3 Hz, H-20’), 1.89 (1H, m, H-15), 1.87 (1H, m, H-16’), 
1.68 (1H, m, H-1'), 1.66 (1H, m, H-11), 1.63 (1H, m, H-12), 1.57 
(1H, m, H-15'), 1.47 (1H, qd, J = 12.7, 3.6 Hz, H-11), 1.37 (1H, m, 
C-12'), 1.36 (1H, m, H-14), 1.20 (1H, m, J = 13.2, 7.5, 2.5 Hz, H-9), 
1.13 (3H, s, H-19), 1.04 (3H, s, H-18); 13C-NMR (176 MHz, CDCl3) 
δC = 199.57 (C-3), 176.74 (C-22), 163.20 (C-5), 139.56 (C-7), 128.50 
(C-6), 124.14 (C-4), 95.52 (C-17), 50.58 (C-9), 47.17 (C-14), 46.59 
(C-13), 37.95 (C-8), 36.19 (C-6), 35.63 (C-16), 34.09 (C-1), 34.05 
(C-2), 31.78 (C-12), 31.33 (C-20), 29.41 (C-21), 22.62 (C-15), 20.25 
(C-11), 16.49 (C-19), 14.58 (C-18); HRESIMS m/z 341.2117 [M  + 
H + ] + 363.1943 [M  +  Na + ] + 703.3992 [2M  +  Na + ] (calcd. for 
C22H28O3). Data compared to the reference Preisig et al. [55].
Damsine (2): white crystalline solid; m.p. = 107ºC; 1H-NMR 
(700 MHz, MeOD) δH = 6.18 (1H, d, J = 3.2 Hz, H-14), 5.64 (1H, d, 
J = 2.8 Hz, H-14’), 4.59 (1H, d, J = 8.7 Hz, H-6), 3.40 (1H, dddd, 
J = 11.7, 6.1, 4.6, 3.1 Hz, H-7), 2.40 (2H, H-3, H-3’), 2.19 (1H, m, 
H-10), 2.18 (1H, m, H-1), 2.03 (2H, m, H-8, H-8’), 1.90 (1H, dddd, 
J = 14.8, 7.8, 4.6, 1.8 Hz, H-2), 1.84 (1H, ddd, J = 11.8, 5.5, 1.4 Hz, 
H-2’), 1.79 (2H, m, H-9, H-9’), 1.08 (3H, d, J = 7.2 Hz, H-15), 1.03 
(3H, s, H-11); 13C-NMR (176 MHz, MeOD) δC = 222.13 (C-4), 172.65 
(C-13), 141.65 (C-12), 121.58 (C-14), 83.68 (C-6), 56.22 (C-5), 
47.09 (C-1), 45.57 (C-7), 36.83 (C-3), 35.76 (C-10), 34.41 (C-9), 
26–61 (C-2), 24.99 (C-8), 16.22 (C-15), 14.23 (C-11); m/z 249.1496 
[M  +  H + ]  + 271.1316 [2M  +  Na + ] (calcd. for C15H20O3). Data com-
pared to the reference Li et al. [56].
Scoparone (3): amber crystalline solid; m.p. = 144ºC; 1H-NMR 
(700 MHz, CDCl3): δH = 7.62 (1H, d, J = 9.4 Hz, H-4), 6.85 (d, 
J = 5.4 Hz, H-5 and H-8), 6.29 (1H, d, J = 9.4 Hz, H-3), 3.95 (3H, s, 
6-OMe), 3.92 (3H, s, 7-OMe); 13C-NMR (176 MHz, CDCl3) 
δC = 161.57 (C-2), 152.99 (C-7), 150.19 (C-9), 146.49 (C-6), 143.44 
(C-4), 113.72 (C-3), 111.58 (C-10), 108.09 (C-5), 100.17 (C-8), 
56.53 (OMe-6), 56.50 (OMe-7); m/z 207.0598 [M  +  H + ]  + 229.0480 
[M  +  Na + ] (calcd. for C11H10O4). Data compared to that of Ma 
et al. [57].
Supporting Information
NMR and MS data of the compounds are available as Supporting 
Information.
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